David McDermott
MD
Director, Kidney Cancer Center
👥Biography 个人简介
David McDermott is a prominent kidney cancer immunotherapy investigator who has led key trials of atezolizumab-bevacizumab and other IO combinations in RCC. He has contributed to understanding biomarkers of response to immunotherapy and belzutifan-based regimens. His clinical research has advanced treatment options for both favorable and poor-risk RCC patients.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 David McDermott 的研究动态
Follow David McDermott's research updates
留下邮箱，当我们发布与 David McDermott（Beth Israel Deaconess Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment